Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SMMT
#672
Summit Therapeutics Inc. Common Stock
16.590
0
+7.66%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+7.66%
Monthly Change
+4.60%
6 month change
-16.47%
Year Change
-16.47%
Previous Close
15.410
0
Open
16.590
0
Bid
Ask
Low
16.590
0
High
16.590
0
Volume
263
Markets
US Stock Market
Healthcare
SMMT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
Citizens reiterates Summit Therapeutics stock rating on pipeline expansion
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript
Summit Therapeutics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SMMT) 2026-02-23
Summit Q4 2025 slides: clinical wins offset by 389% EPS miss
Earnings call transcript: Summit Therapeutics Q4 2025 reports significant EPS miss
Summit Therapeutics falls on earnings miss despite progress
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.
Summit Therapeutics stock hits 52-week low at 14.01 USD